Chenglai Xia
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
-
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
-
- RNA Interference and Gene Delivery 1
- Surgery 1
- Vascular Malformations and Hemangiomas 1
- Co-authors
- Kenneth K.W. To (2 shared papers)Liwu Fu (2 shared papers)Shuanghong Yin (1 shared paper)Hao Hu (3 shared papers)Jiyan Su (2 shared papers)Xiaodan Zhu (1 shared paper)Linghua Zhang (1 shared paper)Zehua Cheng (1 shared paper)
In The Last Decade
Chenglai Xia
7 papers receiving 286 citations
Chenglai Xia's Hit Papers
Peers
Comparison fields: 5 of 61
- Physiology 77
- Immunology 94
- Oncology 78
- Genetics 20
- Cancer Research 19
Countries citing papers authored by Chenglai Xia
This map shows the geographic impact of Chenglai Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglai Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglai Xia more than expected).
Fields of papers citing papers by Chenglai Xia
This network shows the impact of papers produced by Chenglai Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglai Xia. The network helps show where Chenglai Xia may publish in the future.
Co-authors
The 23 scholars most cited alongside Chenglai Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CD39/CD73/A2AR pathway and cancer immunotherapy Hit paper breakdown → | 2023 | 234 |
| 2 | 2020 | 16 | |
| 3 | 2025 | 13 | |
| 4 | 2021 | 11 | |
| 5 | 2024 | 7 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 1 | |
| 8 | 2022 | 0 |
About Chenglai Xia
Chenglai Xia is a scholar working on Molecular Biology, Surgery, Pharmacology, Genetics and Pathology and Forensic Medicine, having authored 8 papers that have together received 289 indexed citations. Recurring topics across this work include Advanced Nanomaterials in Catalysis (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Vascular Malformations and Hemangiomas (1 paper), Adenosine and Purinergic Signaling (1 paper), Berberine and alkaloids research (1 paper), RNA Interference and Gene Delivery (1 paper), Nanocluster Synthesis and Applications (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Physiology (77 citations), Immunology (94 citations), Oncology (78 citations), Genetics (20 citations) and Cancer Research (19 citations). Chenglai Xia has collaborated with scholars based in China, Macao and Hong Kong. Frequent co-authors include Kenneth K.W. To, Liwu Fu, Shuanghong Yin, Hao Hu, Jiyan Su, Xiaodan Zhu, Linghua Zhang, Zehua Cheng, Mai Luo and Yan Xue. Their work appears in journals such as Molecular Cancer, Biosensors, Medicine, Cell Communication and Signaling and Chinese Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.